Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 2
1998 1
1999 2
2006 1
2007 1
2008 1
2009 1
2010 4
2011 2
2012 4
2013 1
2014 4
2015 5
2016 7
2017 6
2018 2
2019 7
2020 5
2021 7
2022 5
2023 4
2024 6
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update.
Rüegg L, Pluma A, Hamroun S, Cecchi I, Perez-Garcia LF, Anderson PO, Andreoli L, Wirström SB, Boyadhzieva V, Chambers C, Costedoat-Chalumeau N, Dolhain RJEM, Fischer-Betz R, Giles I, Gøtestam-Skorpen C, Hoeltzenbein M, Marchiori F, Mayer-Pickel K, Molto A, Nelson-Piercy C, Nielsen OH, Tincani A, Wallenius M, Zbinden A, Meissner Y, Finckh A, Förger F. Rüegg L, et al. Ann Rheum Dis. 2025 Jun;84(6):910-926. doi: 10.1016/j.ard.2025.02.023. Epub 2025 Apr 26. Ann Rheum Dis. 2025. PMID: 40287311 Free article.
The current evidence indicates that synthetic disease-modifying antirheumatic drugs (DMARDs) compatible with pregnancy include antimalarials, azathioprine, colchicine, cyclosporine, sulfasalazine, and tacrolimus. ...Based on an individualised risk-benefit assessment, all t …
The current evidence indicates that synthetic disease-modifying antirheumatic drugs (DMARDs) compatible with pregnancy include antima …
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study.
Andreoli L, Gerardi MC, Gerosa M, Rozza D, Crisafulli F, Erra R, Lini D, Trespidi L, Padovan M, Ruffilli F, Serale F, Cuomo G, Raffeiner B, Semeraro P, Tani C, Chimenti MS, Conigliaro P, Hoxha A, Nalli C, Fredi M, Lazzaroni MG, Filippini M, Taglietti M, Franceschini F, Zatti S, Loardi C, Orabona R, Ramazzotto F, Zanardini C, Fontana G, Gozzoli G, Barison C, Bizioli P, Caporali RF, Carrea G, Ossola MW, Maranini B, Silvagni E, Govoni M, Morano D, Verteramo R, Doria A, Del Ross T, Favaro M, Calligaro A, Tonello M, Larosa M, Zen M, Zambon A, Mosca M, Zucchi D, Elefante E, Gori S, Iannone F, Anelli MG, Lavista M, Abbruzzese A, Fasano CG, D'Angelo S, Cutro MS, Picerno V, Carbone T, Padula AA, Rovere-Querini P, Canti V, De Lorenzo R, Cavallo L, Ramoni V, Montecucco C, Codullo V, Milanesi A, Pazzola G, Comitini G, Marvisi C, Salvarani C, Epis OM, Benedetti S, Di Raimondo G, Gagliardi C, Lomater C, Crepaldi G, Bellis E, Bellisai F, Garcia Gonzalez E, Pata AP, Zerbinati M, Urban ML, Mattioli I, Iuliano A, Sebastiani G, Brucato AL, Bizzi E, Cutolo M, Santo L, Tonetta S, Landolfi G, Carrara G, Bortoluzzi A, Scirè CA, Tincani A; P-RHEUM.it Investigators of the Italian Society for Rheumatology … See abstract for full author list ➔ Andreoli L, et al. RMD Open. 2024 Apr 24;10(2):e004091. doi: 10.1136/rmdopen-2024-004091. RMD Open. 2024. PMID: 38663885 Free PMC article.
OBJECTIVES: To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective cohort study P-RHEUM.it. METHODS: Pregnant women with different ARD were enrolled for up to 20 gestational weeks in 29 Rheumatology Centres for …
OBJECTIVES: To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective coh …
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Russell MD, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):e48-e88. doi: 10.1093/rheumatology/keac551. Rheumatology (Oxford). 2023. PMID: 36318966 Free PMC article. No abstract available.
Stratifying management of rheumatic disease for pregnancy and breastfeeding.
Giles I, Yee CS, Gordon C. Giles I, et al. Nat Rev Rheumatol. 2019 Jul;15(7):391-402. doi: 10.1038/s41584-019-0240-8. Epub 2019 Jun 11. Nat Rev Rheumatol. 2019. PMID: 31186540 Review.
The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change in the past few years. Modern therapeutics, including biologic and targeted synthetic DMARDs, have enabled substantial improvements i …
The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change …
The Role of TNF-alpha and Anti-TNF-alpha Agents during Preconception, Pregnancy, and Breastfeeding.
Romanowska-Próchnicka K, Felis-Giemza A, Olesińska M, Wojdasiewicz P, Paradowska-Gorycka A, Szukiewicz D. Romanowska-Próchnicka K, et al. Int J Mol Sci. 2021 Mar 13;22(6):2922. doi: 10.3390/ijms22062922. Int J Mol Sci. 2021. PMID: 33805757 Free PMC article. Review.
Furthermore, early pregnancy placenta has a direct impact on fetal development and maternal immune system diseases that release inflammatory (e.g., TNF-alpha) and immunomodulatory factors, such as chronic inflammatory rheumatic, gastroenterological, or dermat …
Furthermore, early pregnancy placenta has a direct impact on fetal development and maternal immune system diseases that release infla …
Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road.
Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Beltagy A, et al. Front Pharmacol. 2021 Feb 11;12:621247. doi: 10.3389/fphar.2021.621247. eCollection 2021. Front Pharmacol. 2021. PMID: 34122062 Free PMC article. Review.
Biologic therapies are increasingly prescribed to treat and maintain remission in a significant number of systemic autoimmune rheumatic diseases. ...Still, long-term data about children born to women treated with biologics in pregnancy are not attainab …
Biologic therapies are increasingly prescribed to treat and maintain remission in a significant number of systemic autoimmune rheu …
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11(th) International Conference on Reproduction, Pregnancy and Rheumatic Diseases.
Andreoli L, Chighizola CB, Iaccarino L, Botta A, Gerosa M, Ramoni V, Tani C, Bermas B, Brucato A, Buyon J, Cetin I, Chambers CD, Clowse MEB, Costedoat-Chalumeau N, Cutolo M, De Carolis S, Dolhain R, Fazzi EM, Förger F, Giles I, Haase I, Khamashta M, Levy RA, Meroni PL, Mosca M, Nelson-Piercy C, Raio L, Salmon J, Villiger P, Wahren-Herlenius M, Wallenius M, Zanardini C, Shoenfeld Y, Tincani A. Andreoli L, et al. Autoimmun Rev. 2023 Mar;22(3):103259. doi: 10.1016/j.autrev.2022.103259. Epub 2022 Dec 20. Autoimmun Rev. 2023. PMID: 36549355 Free article. Review.
Autoimmune rheumatic diseases (ARD) can affect women and men during fertile age, therefore reproductive health is a priority issue in rheumatology. Many topics need to be considered during preconception counselling: fertility, the impact of disease-related …
Autoimmune rheumatic diseases (ARD) can affect women and men during fertile age, therefore reproductive health is a priority i …
Medications in pregnancy and breastfeeding.
Tosounidou S, Gordon C. Tosounidou S, et al. Best Pract Res Clin Obstet Gynaecol. 2020 Apr;64:68-76. doi: 10.1016/j.bpobgyn.2019.10.007. Epub 2019 Nov 15. Best Pract Res Clin Obstet Gynaecol. 2020. PMID: 32019728 Review.
Advances in therapeutics, including a wider use of biologics and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) have substantially improved the management of rheumatic diseases, resulting in more women with severe disease …
Advances in therapeutics, including a wider use of biologics and targeted synthetic disease-modifying anti-rheumatic dr …
Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology.
Manara M, Bruno D, Ferrito M, Perniola S, Caporali RF, Gremese E. Manara M, et al. Reumatismo. 2024 Sep 11;76(3). doi: 10.4081/reumatismo.2024.1781. Reumatismo. 2024. PMID: 39282774 Free article. Review.
METHODS: We performed a narrative review of national and international recommendations and guidelines on the reproductive health of patients suffering from rheumatic diseases. The last updated recommendations and guidelines were considered source data. RESULTS: We r …
METHODS: We performed a narrative review of national and international recommendations and guidelines on the reproductive health of patients …
80 results